Skip to main content

Advertisement

Log in

The sensitivity of human cells expressing RUNX1-RUNX1T1 to chemotherapeutic agents

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Peterson LF, Zhang DE . The 8;21 translocation in leukemogenesis. Oncogene 2004; 23: 4255–4262.

    Article  CAS  Google Scholar 

  2. Tonks A, Tonks AJ, Pearn L, Pearce L, Hoy T, Couzens S et al. Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal. Leukemia 2004; 18: 1238–1245.

    Article  CAS  Google Scholar 

  3. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.

    CAS  Google Scholar 

  4. Lutterbach B, Sun D, Schuetz J, Hiebert SW . The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol 1998; 18: 3604–3611.

    Article  CAS  Google Scholar 

  5. Pearson L, Leith CP, Duncan MH, Chen IM, McConnell T, Trinkaus K et al. Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia. Leukemia 1996; 10: 1274–1282.

    CAS  PubMed  Google Scholar 

  6. Schaich M, Harbich-Brutscher E, Pascheberg U, Mohr B, Soucek S, Ehninger G et al. Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome. Haematologica 2002; 87: 455–464.

    CAS  PubMed  Google Scholar 

  7. Tonks A, Pearn L, Musson M, Gilkes A, Mills K, Burnett A et al. RUNX1-RUNXIT1 induces over-expression of gamma-catenin in human CD34(+) cells, increasing self renewal and impairing granulocytic differentiation. Blood 2005; 106: 841A.

    Article  Google Scholar 

  8. Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 2001; 98: 10398–10403.

    Article  CAS  Google Scholar 

  9. Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol 2004; 24: 2890–2904.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Amanda Gilkes and Megan Musson (Cardiff University) for their technical assistance in processing microarray samples. We are grateful to the MRC for access to patient sample material enrolled in the NCRI clinical trials. This work was supported by Leukaemia Research, UK.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tonks, A., Pearn, L., Mills, K. et al. The sensitivity of human cells expressing RUNX1-RUNX1T1 to chemotherapeutic agents. Leukemia 20, 1883–1885 (2006). https://doi.org/10.1038/sj.leu.2404364

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404364

  • Springer Nature Limited

Navigation